Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

1.

Early and long-term morbidity after minimally invasive total laryngo-pharyngo-esophagectomy with gastric pull-up reconstruction via thoracoscopy, laparoscopy and cervical incision.

Homma A, Nakamaru Y, Hatakeyama H, Mizumachi T, Kano S, Furusawa J, Sakashita T, Shichinohe T, Ebihara Y, Hirano S, Furukawa H, Hayashi T, Yamamoto Y, Fukuda S.

Eur Arch Otorhinolaryngol. 2014 Dec 5. [Epub ahead of print]

PMID:
25476198
[PubMed - as supplied by publisher]
2.

Comparative Study of the Sensitivities of Cancer Cells to Doxorubicin, and Relationships between the Effect of the Drug-Efflux Pump P-gp.

Kibria G, Hatakeyama H, Akiyama K, Hida K, Harashima H.

Biol Pharm Bull. 2014;37(12):1926-35.

PMID:
25451842
[PubMed - in process]
Free Article
3.

Advances in an active and passive targeting to tumor and adipose tissues.

Sakurai Y, Kajimoto K, Hatakeyama H, Harashima H.

Expert Opin Drug Deliv. 2015 Jan;12(1):41-52. doi: 10.1517/17425247.2015.955847. Epub 2014 Nov 7.

PMID:
25376864
[PubMed - in process]
4.

The potential diagnostic role of the number of ultrasonographic characteristics for patients with thyroid nodules evaluated as bethesda I-v.

Sakashita T, Homma A, Hatakeyama H, Mizumachi T, Kano S, Furusawa J, Iizuka S, Hoshino K, Hatanaka KC, Oba K, Fukuda S.

Front Oncol. 2014 Sep 23;4:261. doi: 10.3389/fonc.2014.00261. eCollection 2014.

PMID:
25295229
[PubMed]
Free PMC Article
5.

Epithelial-mesenchymal transition in human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma.

Hatakeyama H, Mizumachi T, Sakashita T, Kano S, Homma A, Fukuda S.

Oncol Rep. 2014 Dec;32(6):2673-9. doi: 10.3892/or.2014.3509. Epub 2014 Sep 22.

PMID:
25241968
[PubMed - in process]
6.

Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain.

Tamaru M, Akita H, Nakatani T, Kajimoto K, Sato Y, Hatakeyama H, Harashima H.

Int J Nanomedicine. 2014 Sep 8;9:4267-76. doi: 10.2147/IJN.S65402. eCollection 2014.

PMID:
25228805
[PubMed - in process]
Free PMC Article
7.

Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.

Mizumachi T, Homma A, Kakizaki T, Sakashita T, Kano S, Hatakeyama H, Tsuchiya K, Yasuda K, Onimaru R, Shirato H, Taguchi J, Shimizu Y, Kinoshita I, Akita H, Fukuda S.

Int J Clin Oncol. 2014 Jul 5. [Epub ahead of print]

PMID:
24993675
[PubMed - as supplied by publisher]
8.

An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.

Ara MN, Matsuda T, Hyodo M, Sakurai Y, Hatakeyama H, Ohga N, Hida K, Harashima H.

Biomaterials. 2014 Aug;35(25):7110-20. doi: 10.1016/j.biomaterials.2014.04.087. Epub 2014 May 27.

PMID:
24875764
[PubMed - in process]
9.

Improvement of doxorubicin efficacy using liposomal anti-polo-like kinase 1 siRNA in human renal cell carcinomas.

Sakurai Y, Hatakeyama H, Akita H, Harashima H.

Mol Pharm. 2014 Aug 4;11(8):2713-9. doi: 10.1021/mp500245z. Epub 2014 May 12.

PMID:
24800640
[PubMed - in process]
10.

In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus.

Watanabe T, Hatakeyama H, Matsuda-Yasui C, Sato Y, Sudoh M, Takagi A, Hirata Y, Ohtsuki T, Arai M, Inoue K, Harashima H, Kohara M.

Sci Rep. 2014 Apr 23;4:4750. doi: 10.1038/srep04750.

PMID:
24756133
[PubMed - in process]
Free PMC Article
11.

Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes.

Hayashi Y, Suemitsu E, Kajimoto K, Sato Y, Akhter A, Sakurai Y, Hatakeyama H, Hyodo M, Kaji N, Baba Y, Harashima H.

Mol Ther Nucleic Acids. 2014 Mar 18;3:e154. doi: 10.1038/mtna.2014.4.

PMID:
24643205
[PubMed]
Free PMC Article
12.

High level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patients.

Sato H, Hatanaka KC, Hatanaka Y, Hatakeyama H, Hashimoto A, Matsuno Y, Fukuda S, Sabe H.

Cell Commun Signal. 2014 Mar 12;12:17. doi: 10.1186/1478-811X-12-17.

PMID:
24621372
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.

Wu SY, Yang X, Gharpure KM, Hatakeyama H, Egli M, McGuire MH, Nagaraja AS, Miyake TM, Rupaimoole R, Pecot CV, Taylor M, Pradeep S, Sierant M, Rodriguez-Aguayo C, Choi HJ, Previs RA, Armaiz-Pena GN, Huang L, Martinez C, Hassell T, Ivan C, Sehgal V, Singhania R, Han HD, Su C, Kim JH, Dalton HJ, Kovvali C, Keyomarsi K, McMillan NA, Overwijk WW, Liu J, Lee JS, Baggerly KA, Lopez-Berestein G, Ram PT, Nawrot B, Sood AK.

Nat Commun. 2014 Mar 12;5:3459. doi: 10.1038/ncomms4459.

PMID:
24619206
[PubMed - in process]
Free PMC Article
14.

Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy.

Sakashita T, Homma A, Hatakeyama H, Kano S, Mizumachi T, Furusawa J, Yoshida D, Fujima N, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Suzuki F, Fukuda S.

Br J Oral Maxillofac Surg. 2014 Apr;52(4):323-8. doi: 10.1016/j.bjoms.2014.01.018. Epub 2014 Feb 26.

PMID:
24582012
[PubMed - in process]
15.

An apolipoprotein E modified liposomal nanoparticle: ligand dependent efficiency as a siRNA delivery carrier for mouse-derived brain endothelial cells.

Tamaru M, Akita H, Kajimoto K, Sato Y, Hatakeyama H, Harashima H.

Int J Pharm. 2014 Apr 25;465(1-2):77-82. doi: 10.1016/j.ijpharm.2014.02.016. Epub 2014 Feb 12.

PMID:
24530390
[PubMed - indexed for MEDLINE]
16.

The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice.

Hatakeyama H, Murata M, Sato Y, Takahashi M, Minakawa N, Matsuda A, Harashima H.

J Control Release. 2013 Oct 25. pii: S0168-3659(13)00872-9. doi: 10.1016/j.jconrel.2013.10.023. [Epub ahead of print]

PMID:
24512791
[PubMed - as supplied by publisher]
17.

The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice.

Hatakeyama H, Murata M, Sato Y, Takahashi M, Minakawa N, Matsuda A, Harashima H.

J Control Release. 2014 Jan 10;173:43-50.

PMID:
24511611
[PubMed - indexed for MEDLINE]
18.

Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.

Kibria G, Hatakeyama H, Harashima H.

Arch Pharm Res. 2014 Jan;37(1):4-15. doi: 10.1007/s12272-013-0276-2. Epub 2013 Nov 23. Review.

PMID:
24272889
[PubMed - indexed for MEDLINE]
19.

The incidence of late neck recurrence in N0 maxillary sinus squamous cell carcinomas after superselective intra-arterial chemoradiotherapy without prophylactic neck irradiation.

Sakashita T, Homma A, Hatakeyama H, Kano S, Mizumachi T, Furusawa J, Yoshida D, Fujima N, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S.

Eur Arch Otorhinolaryngol. 2014 Oct;271(10):2767-70. doi: 10.1007/s00405-013-2806-4. Epub 2013 Nov 9.

PMID:
24213278
[PubMed - in process]
20.

Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.

Homma A, Sakashita T, Yoshida D, Onimaru R, Tsuchiya K, Suzuki F, Yasuda K, Hatakeyama H, Furusawa J, Mizumachi T, Kano S, Inamura N, Taki S, Shirato H, Fukuda S.

Br J Cancer. 2013 Dec 10;109(12):2980-6. doi: 10.1038/bjc.2013.663. Epub 2013 Nov 5.

PMID:
24196792
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk